Search

Your search keyword '"Levine, R. A."' showing total 118 results

Search Constraints

Start Over You searched for: Author "Levine, R. A." Remove constraint Author: "Levine, R. A." Publisher springer science and business media llc Remove constraint Publisher: springer science and business media llc
118 results on '"Levine, R. A."'

Search Results

2. Patient-derived xenotransplants can recapitulate the genetic driver landscape of acute leukemias

4. Dnmt3a regulates myeloproliferation and liver-specific expansion of hematopoietic stem and progenitor cells

8. Mutated Ptpn11 alters leukemic stem cell frequency and reduces the sensitivity of acute myeloid leukemia cells to Mcl1 inhibition

9. Acceleration of Bcr-Abl+ leukemia induced by deletion of JAK2

11. Point mutation E1099K in MMSET/NSD2 enhances its methyltranferase activity and leads to altered global chromatin methylation in lymphoid malignancies

13. Toll-like receptor alterations in myelodysplastic syndrome

14. AKT is a therapeutic target in myeloproliferative neoplasms

15. Global H3K4me3 genome mapping reveals alterations of innate immunity signaling and overexpression of JMJD3 in human myelodysplastic syndrome CD34+ cells

17. Somatic MED12 mutations in uterine leiomyosarcoma and colorectal cancer

21. Analysis of genomic aberrations and gene expression profiling identifies novel lesions and pathways in myeloproliferative neoplasms

22. Safety, efficacy and biological predictors of response to sequential azacitidine and lenalidomide for elderly patients with acute myeloid leukemia

29. Mutations with epigenetic effects in myeloproliferative neoplasms and recent progress in treatment: Proceedings from the 5th International Post-ASH Symposium

31. PHF6 mutations in adult acute myeloid leukemia

34. IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosis

36. Accurate detection of uniparental disomy and microdeletions by SNP array analysis in myelodysplastic syndromes with normal cytogenetics

38. TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis

46. TG101209, a small molecule JAK2-selective kinase inhibitor potently inhibits myeloproliferative disorder-associated JAK2V617F and MPLW515L/K mutations

Catalog

Books, media, physical & digital resources